top of page

Misson Statement

DSCF0936_edited.jpg

Dr. Peter J. Gaskill

Our research  explores the immunopharmacology of neurotransmitters, addictive drugs and neuropsychiatric therapeutics in neurological and inflammatory disease. Currently, our projects focus on the impact of dopamine on inflammasome activity, the role of addictive substances (cocaine, benzodiazepines) on HIV replication and associated inflammation in the brain, the impact of HIV / HBV co-infection and stimulants on HIV infection in liver and lung macrophages, and the development of iPSC models of microglia, macrophages, human cortical and mid-brain organoids to facilitate our understanding and research into neuroHIV and other neurodegenerative diseases. A common thread throughout these projects is a focus on myeloid cells, a central driver of innate inflammation as well as a primary target for HIV infection in many organ systems. We use primary human macrophages from blood and tissues as well as iPSC-derived macrophages and microglia, and many of our experiments use high-content imaging to perform unbiased, high-throughput analysis of large, heterogenous cell populations and molecular targets in response to many distinct stimuli. Combining these high content analyses with molecular and cell biology techniques enables us to focus specifically on the molecular mechanisms regulating the involvement of myeloid cells in disease processes. 

Gaskill Lab News

January 2026

The Qiang and Gaskill labs received a new WW Smith Foundation award "Next-generation human brain organoids uncover mechanisms and therapeutic targets for glutamate dysregulation and vascular injury in HIV-associated neurodegeneration"

December 2025

Tofunmi Oteju and Marzieh Daniali both received honorable mention for the Ben Weiss Award from the Department of Pharmacology and Physiology!!

Marzieh Daniali received the Mary Shaw travel award from the Department of Pharmacology and Physiology and the Dean's travel Award from Drexel University College of Medicine!!

 

November 2025

Congratulations to Amanda Modica, for receiving 1st place in the Junior Graduate Student Poster Competition, and to Tofunmi Oteju, for receiving 3rd place in the Senior Graduate Student Poster Competition, at Discovery Day in 2025!

October 2025

Our collaboration with Dr. Alex Starr and the Jordan-Scuitto Lab on the impact of cannabinoid receptors on HIV replication in microglia was published in the Journal of Neuroimmune Pharmacology

September 2025

Excited to announce the publication of our review on the The Role of Liver Macrophages in Viral Liver Pathogenesis, able led by Alexis Brantly, was published in the Journal of Leukocyte Biology

 

August 2025

Alexis Brantly did fantastic job today defending her thesis focused on "Establishing a model of HIV infection in macrophages to assess HIV / HBV co-infection driven liver disease". Keep an eye here for great data coming out soon about HIV / HBV coinfection.

The Gaskill lab received our notice of award for our R33, funding our research Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV !!!

Recent Publications

The Role of Liver Macrophages in Viral Liver Pathogenesis
Journal of Leukocyte Biology        September 2025
Dopamine-driven increase in IL-1β in myeloid cells is mediated by differential dopamine receptor expression and exacerbated by HIV
Journal of Neuroinflammation    March 2025
Microenvironmental Conditions and Serum Availability Alter Primary Human Macrophage NF-κB Inflammatory Response and Function
Journal of Leukocyte Biology    May 2025
Dopamine, Immunity and Disease
Pharmacological Reviews    January 2023
bottom of page